Healthy Skepticism Library item: 17382
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: news
THE 2002 FORTUNE 500 report on the Pharmaceutical Industry
2002 Apr 15
Full text:
The following 3 tables are edited from:
http://www.fortune.com/lists/F500/topperf_ind_mostprofit_rev.html
http://www.fortune.com/lists/F500/topperf_ind_mostprofit_asset.html
http://www.fortune.com/lists/F500/topperf_ind_mostprofit_equity.html
The following 3 tables present data from Fortune Magazine for the top 5 industries by each of those 3 measures plus the Computers, Office Equipment industry for comparison. The computer and office equipment industry is a useful comparator because like the pharmaceutical industry it is a high technology manufacturing industry but unlike the pharmaceutical industry it has produced continuous improvements over the past 50 years in quality and in cost effectiveness.
TOP 5 INDUSTRIES plus
Computers, Office Equipment
Return on Revenues
Industry Rank
Industry
2001 Profits as % of Revenues
1
Pharmaceuticals
18.5
2
Commercial Banks
13.5
3
Diversified Financials
10.9
4
Mining, Crude-Oil Production
8.6
5
Household Products
8.3
23
Computers, Office Equipment
2.3
TOP 5 INDUSTRIES plus
Computers, Office Equipment
Return on Assets
Industry Rank
Industry
2001 Profits as % of Assets
1
Pharmaceuticals
16.3
2
Household Products
9.5
3
Beverages
8.1
4
Apparel
7.0
5
Food Consumer Products
6.4
19
Computers, Office Equipment
2.9
TOP 5 INDUSTRIES plus
Computers, Office Equipment
Return on Shareholders’ Equity
Industry Rank
Industry
2001 Profits as % of Equity
1
Pharmaceuticals
33.2
2
Household Products
26.4
3
Beverages
25.2
4
Food Consumer Products
20.8
5
Homebuilders
19.6
35
Computers, Office Equipment
5.8
The following is copied from:http://www.fortune.com/lists/F500/indsnap_41.html
Industry Rankings
See how the FORTUNE 1,000 stack up in their industries.
View FORTUNE 500 by:
Full List Company CEO Industry Top Performers Arrivals Displaced
INDUSTRY: Pharmaceuticals
Rank Company 1,000 Revenues Rank Revenues Profits Profits as % of Earnings per share Total Return to Investors Employees
$ millions % Change From 2000 $ millions % Change From 2000 Revenues % Assets % Stock- holders’ Equity % 1991 – 2001 Annual Rate () 1991 – 2001 Annual Rate () 2001 (%) Number % Change From 2000
1 Merck 24 47,716 18 7,282 7 15 17 45 13 10 -36 78,000 13
2 Johnson & Johnson 47 33,004 13 5,668 18 17 15 23 13 17 14 101,800 3
3 Pfizer 49 32,259 9 7,788 109 24 20 43 21 21 -13 90,000 0
4 Bristol-Myers Squibb 96 21,717 2 5,245 11 24 19 49 11 13 -26 46,000 -10
5 Pharmacia 105 19,299 4 1,501 109 8 7 12 9 15 -29 59,600 1
6 Abbott Laboratories 123 16,285 19 1,550 -44 10 7 17 5 15 17 71,426 18
7 Wyeth 145 14,129 2 2,285 N/A 16 10 56 5 15 -2 52,219 9
8 Eli Lilly 171 11,543 6 2,780 -9 24 17 39 9 17 -14 41,100 15
9 Schering-Plough 196 9,802 0 1,943 -20 20 16 27 13 18 -36 29,800 6
10 Amgen 403 4,016 11 1,120 -2 28 17 22 29 20 -12 7,700 6
11 Allergan 788 1,685 8 225 5 13 11 23 N/A 21 -22 6,436 4
12 Genzyme 971 1,224 36 -112 N/A -9 -3 -4 N/A N/A N/A 5,200 18
13 Ivax 976 1,215 53 243 86 20 12 34 27 0 -34 8,175 74
14 Forest Laboratories 982 1,205 34 215 91 18 15 18 18 23 23 2,826 14
TOTAL — — 215,098 — 37,733 — — — — — — — 600,282 —
From the April 15, 2002 Issue